SMAD family member 6, also known as SMAD6, is a protein that in humans is encoded by the SMAD6gene.1
SMAD6 is a protein that, as its name describes, is a homolog of the Drosophila gene "mothers against decapentaplegic". It belongs to the SMAD family of proteins, which belong to the TGFβ superfamily of modulators. Like many other TGFβ family members SMAD6 is involved in cell signalling. It acts as a regulator of TGFβ family (such as bone morphogenetic proteins) activity by competing with SMAD4 and preventing the transcription of SMAD4's gene products. There are two known isoforms of this protein.
The SMAD proteins are homologs of both the drosophila protein, mothers against decapentaplegic (MAD) and the C. elegans protein SMA. The name is a combination of the two. During Drosophila research, it was found that a mutation in the gene MAD in the mother repressed the gene decapentaplegic in the embryo. The phrase "Mothers against" was added since mothers often form organizations opposing various issues, e.g., Mothers Against Drunk Driving, or (MADD).
^Kimura, N; Matsuo R, Shibuya H, Nakashima K, Taga T (June 2000). "BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6". J. Biol. Chem. (UNITED STATES) 275 (23): 17647–52. doi:10.1074/jbc.M908622199. ISSN0021-9258. PMID10748100.
^Yanagisawa, M; Nakashima K, Takeda K, Ochiai W, Takizawa T, Ueno M, Takizawa M, Shibuya H, Taga T (December 2001). "Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7". Genes Cells (England) 6 (12): 1091–9. doi:10.1046/j.1365-2443.2001.00483.x. ISSN1356-9597. PMID11737269.
Riggins GJ, Thiagalingam S, Rozenblum E et al. (1996). "Mad-related genes in the human". Nat. Genet.13 (3): 347–9. doi:10.1038/ng0796-347. PMID8673135.
Afrakhte M, Morén A, Jossan S et al. (1998). "Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members". Biochem. Biophys. Res. Commun.249 (2): 505–11. doi:10.1006/bbrc.1998.9170. PMID9712726.
Galvin KM, Donovan MJ, Lynch CA et al. (2000). "A role for smad6 in development and homeostasis of the cardiovascular system". Nat. Genet.24 (2): 171–4. doi:10.1038/72835. PMID10655064.
Bai S, Shi X, Yang X, Cao X (2000). "Smad6 as a transcriptional corepressor". J. Biol. Chem.275 (12): 8267–70. doi:10.1074/jbc.275.12.8267. PMID10722652.
Kimura N, Matsuo R, Shibuya H et al. (2000). "BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6". J. Biol. Chem.275 (23): 17647–52. doi:10.1074/jbc.M908622199. PMID10748100.
Ebisawa T, Fukuchi M, Murakami G et al. (2001). "Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation". J. Biol. Chem.276 (16): 12477–80. doi:10.1074/jbc.C100008200. PMID11278251.
Yanagisawa M, Nakashima K, Takeda K et al. (2002). "Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7". Genes Cells6 (12): 1091–9. doi:10.1046/j.1365-2443.2001.00483.x. PMID11737269.
Schiffer M, Schiffer LE, Gupta A et al. (2003). "Inhibitory smads and tgf-Beta signaling in glomerular cells". J. Am. Soc. Nephrol.13 (11): 2657–66. doi:10.1097/01.ASN.0000033276.06451.50. PMID12397035.